FDA Inspection 1005804 — Laboratory Corporation Of America

Laboratory Corporation Of America — FEI 1000111938

The FDA completed an inspection of Laboratory Corporation Of America on April 3, 2017 in Burlington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 3, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Burlington, NC (United States)